Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Abstract

Patients treated with MMF because of intolerance to first line treatment show a good disease control under MMF in the majority of cases. Efficacy is considerably lower in the patients switched to MMF because of an insufficient response to first line treatment.